Related Experiment Video

Updated: Oct 4, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

1.7K

Multimerin-1 and cancer: a review

Mareike G Posner1

  • 1Department of Life Sciences, Manchester Metropolitan University, Manchester, United Kingdom.

Bioscience Reports
|February 8, 2022
PubMed

Insights

Multimerin-1 (MMRN1) is a platelet protein involved in blood clotting. Its role in cancer development and progression is under investigation, highlighting its potential as a cancer biomarker.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Multimerin-1 (MMRN1) is a platelet protein crucial for hemostasis and coagulation.
  • MMRN1 is also found in endothelial cells (ECs) and the extracellular matrix (ECM), potentially mediating cell adhesion.
  • Its detailed molecular functions and interactions in ECs and ECM remain largely uncharacterized.

Purpose of the Study:

  • To review the current knowledge on Multimerin-1 (MMRN1).
  • To explore the potential role of MMRN1 in cancer development and progression.
  • To highlight MMRN1's significance as a potential cancer biomarker.

Main Methods:

  • Literature review of studies on MMRN1.
  • Analysis of MMRN1's differential gene expression in various cancers.
  • Investigation of MMRN1 regulation by methylation, protein interactions, and non-coding RNAs (ncRNAs).

Main Results:

  • MMRN1 is identified as a differentially expressed gene (DEG) in multiple cancer types.
  • Evidence suggests MMRN1 expression is modulated by epigenetic and post-transcriptional mechanisms in cancer.
  • The differential expression pattern of MMRN1 may correlate with cancer progression.

Conclusions:

  • MMRN1 is a promising candidate for cancer biomarker development.
  • Further research is needed to elucidate MMRN1's molecular mechanisms in cancer.
  • Understanding MMRN1's function can inform novel therapeutic strategies.
Keywords:
biomarkerscancermolecular basis of health and diseasetranscription

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.3K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.5K

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K